Newsletter | January 5, 2023

01.05.23 -- Where Do We Stand On Adopting Continuous Manufacturing For Biologics?

Featured Editorial
Industry Insights
Comparing Vial Container Closure Systems Using The DeltaCube Modeling Platform

Examine a case study where two 20mm vial CCSs were compared using the DeltaCube Modeling Platform and experimentally show the link between prediction and real performance.

Top Four Considerations For Tech Transfer Performance

Successful tech transfer is how long-term strategic CDMO relationships begin. A product’s continued success may hinge on this critical exchange of product data and required regulatory filings.

3 Tips For Purifying His-Tagged Proteins

Tags simplify purification and enable scientists to use standard protocols while also improving the yield, purity, and solubility of the protein of interest.

How Collaboration Transformed A Generic Into A Best-In-Class New Drug

Learn how a drug developer collaborated to transform a generic solid active pharmaceutical ingredient (API) into a commercial sterile injectable approved by regulators.

Viral Safety Of Biologics: What's Changing With The ICH Q5A Revision?

ICH Q5A is currently being revised to address recent scientific advancements. We'll discuss the expected changes and potential impact on viral safety strategies.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.